Loading…
Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT
Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism and hydroxytyrosol (HT; 5 mg/kg/day) exerting antioxidant actions was evalu...
Saved in:
Published in: | Oxidative medicine and cellular longevity 2018-01, Vol.2018 (2018), p.1-13 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143 |
---|---|
cites | cdi_FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143 |
container_end_page | 13 |
container_issue | 2018 |
container_start_page | 1 |
container_title | Oxidative medicine and cellular longevity |
container_volume | 2018 |
creator | Videla, Luis A. Corbari, Alicia Soto-Alarcon, Sandra A. Ortiz, Macarena Álvarez, Daniela Bustamante, Andrés Valenzuela, R. Echeverría, Francisca Muñoz, Patricio |
description | Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism and hydroxytyrosol (HT; 5 mg/kg/day) exerting antioxidant actions was evaluated on hepatic steatosis and oxidative stress induced by a high-fat diet (HFD; 60% fat, 20% protein, and 20% carbohydrates) compared to a control diet (CD; 10% fat, 20% protein, and 70% carbohydrates) in mice fed for 12 weeks. HFD-induced liver steatosis (i) was reduced by 32% by EPA, without changes in oxidative stress-related parameters and mild recovery of Nrf2 functioning affording antioxidation and (ii) was decreased by 42% by HT, concomitantly with total regain of the glutathione status diminished by HFD, 42% to 59% recovery of lipid peroxidation and protein oxidation enhanced by HFD, and regain of Nrf2 functioning, whereas (iii) combined EPA + HT supplementation elicited 74% reduction in liver steatosis, with total recovery of the antioxidant potential in a similar manner than HT. It is concluded that combined HT + EPA drastically decreases NAFLD development, an effect that shows additivity in HT and EPA effects that mainly relies on HT, strengthening the impact of oxidative stress as a central mechanism underlying liver steatosis in obesity. |
doi_str_mv | 10.1155/2018/5109503 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6051008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A602717051</galeid><sourcerecordid>A602717051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143</originalsourceid><addsrcrecordid>eNqNkk1vEzEQhlcIREvhxhlZ4lIES8dr79cFKQotqRRUqYSz5bVnE1cbO6y9ofuT-Jc4JKTAiZNH48fvfPhNkpcU3lOa5xcZ0Ooip1DnwB4lp7TmWQp1zR8fY4CT5Jn3dwAFyzh9mpwwgLwsKnqa_JiEgHaQwThLXEtmZrlKr2QgHw2G9NrqQaEmtzExN1vsyc290RHeIvkSevSeSKtjiDI4bzxpRjJ168bY-Gg26t7dj2HsnXddSs5ni_QNuTTKeblBGyRaZxSZKBMVhs2mw_Uu-6uTz9LYbiS32Bn0JCZmi-fJk1Z2Hl8czrPk69XlYjpL5zefrqeTeap4XYdUV5nSrJYUdF5IzoumaDjlUuuypZIrwLptlcwkawrGNFcNy6qm0G3ciFaUs7Pkw153MzRr1Cr21MtObHqzlv0onDTi7xtrVmLptqKA-AtQRYHzg0Dvvg3og1gbr7DrpEU3eJFBWdd5BqyI6Ot_0Ds39DaOt6OAMsoq_kAtZYfC2NbFumonKiYFZCUtY-VIvdtTKu7b99geW6Ygdk4RO6eIg1Mi_urPMY_wb2tE4O0eWBmr5Xfzn3IYGWzlA51FuAT2Ez330Rg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2070131384</pqid></control><display><type>article</type><title>Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Videla, Luis A. ; Corbari, Alicia ; Soto-Alarcon, Sandra A. ; Ortiz, Macarena ; Álvarez, Daniela ; Bustamante, Andrés ; Valenzuela, R. ; Echeverría, Francisca ; Muñoz, Patricio</creator><contributor>Romero, Francisco J. ; Francisco J Romero</contributor><creatorcontrib>Videla, Luis A. ; Corbari, Alicia ; Soto-Alarcon, Sandra A. ; Ortiz, Macarena ; Álvarez, Daniela ; Bustamante, Andrés ; Valenzuela, R. ; Echeverría, Francisca ; Muñoz, Patricio ; Romero, Francisco J. ; Francisco J Romero</creatorcontrib><description>Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism and hydroxytyrosol (HT; 5 mg/kg/day) exerting antioxidant actions was evaluated on hepatic steatosis and oxidative stress induced by a high-fat diet (HFD; 60% fat, 20% protein, and 20% carbohydrates) compared to a control diet (CD; 10% fat, 20% protein, and 70% carbohydrates) in mice fed for 12 weeks. HFD-induced liver steatosis (i) was reduced by 32% by EPA, without changes in oxidative stress-related parameters and mild recovery of Nrf2 functioning affording antioxidation and (ii) was decreased by 42% by HT, concomitantly with total regain of the glutathione status diminished by HFD, 42% to 59% recovery of lipid peroxidation and protein oxidation enhanced by HFD, and regain of Nrf2 functioning, whereas (iii) combined EPA + HT supplementation elicited 74% reduction in liver steatosis, with total recovery of the antioxidant potential in a similar manner than HT. It is concluded that combined HT + EPA drastically decreases NAFLD development, an effect that shows additivity in HT and EPA effects that mainly relies on HT, strengthening the impact of oxidative stress as a central mechanism underlying liver steatosis in obesity.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2018/5109503</identifier><identifier>PMID: 30057681</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Antioxidants ; Cardiovascular disease ; Chemistry ; Diet ; Drug dosages ; Endoplasmic reticulum ; Fatty acids ; Hepatology ; Inflammation ; Insulin resistance ; Laboratory animals ; Liver diseases ; Nutrition research ; Omega-3 fatty acids ; Oxidative stress ; Pharmaceutical industry ; Physiological aspects ; Proteins ; Rodents ; Unsaturated fatty acids</subject><ispartof>Oxidative medicine and cellular longevity, 2018-01, Vol.2018 (2018), p.1-13</ispartof><rights>Copyright © 2018 Francisca Echeverría et al.</rights><rights>COPYRIGHT 2018 John Wiley & Sons, Inc.</rights><rights>Copyright © 2018 Francisca Echeverría et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2018 Francisca Echeverría et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143</citedby><cites>FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143</cites><orcidid>0000-0001-5055-3795 ; 0000-0002-1788-6667</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2070131384/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2070131384?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30057681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Romero, Francisco J.</contributor><contributor>Francisco J Romero</contributor><creatorcontrib>Videla, Luis A.</creatorcontrib><creatorcontrib>Corbari, Alicia</creatorcontrib><creatorcontrib>Soto-Alarcon, Sandra A.</creatorcontrib><creatorcontrib>Ortiz, Macarena</creatorcontrib><creatorcontrib>Álvarez, Daniela</creatorcontrib><creatorcontrib>Bustamante, Andrés</creatorcontrib><creatorcontrib>Valenzuela, R.</creatorcontrib><creatorcontrib>Echeverría, Francisca</creatorcontrib><creatorcontrib>Muñoz, Patricio</creatorcontrib><title>Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism and hydroxytyrosol (HT; 5 mg/kg/day) exerting antioxidant actions was evaluated on hepatic steatosis and oxidative stress induced by a high-fat diet (HFD; 60% fat, 20% protein, and 20% carbohydrates) compared to a control diet (CD; 10% fat, 20% protein, and 70% carbohydrates) in mice fed for 12 weeks. HFD-induced liver steatosis (i) was reduced by 32% by EPA, without changes in oxidative stress-related parameters and mild recovery of Nrf2 functioning affording antioxidation and (ii) was decreased by 42% by HT, concomitantly with total regain of the glutathione status diminished by HFD, 42% to 59% recovery of lipid peroxidation and protein oxidation enhanced by HFD, and regain of Nrf2 functioning, whereas (iii) combined EPA + HT supplementation elicited 74% reduction in liver steatosis, with total recovery of the antioxidant potential in a similar manner than HT. It is concluded that combined HT + EPA drastically decreases NAFLD development, an effect that shows additivity in HT and EPA effects that mainly relies on HT, strengthening the impact of oxidative stress as a central mechanism underlying liver steatosis in obesity.</description><subject>Antioxidants</subject><subject>Cardiovascular disease</subject><subject>Chemistry</subject><subject>Diet</subject><subject>Drug dosages</subject><subject>Endoplasmic reticulum</subject><subject>Fatty acids</subject><subject>Hepatology</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Laboratory animals</subject><subject>Liver diseases</subject><subject>Nutrition research</subject><subject>Omega-3 fatty acids</subject><subject>Oxidative stress</subject><subject>Pharmaceutical industry</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Unsaturated fatty acids</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk1vEzEQhlcIREvhxhlZ4lIES8dr79cFKQotqRRUqYSz5bVnE1cbO6y9ofuT-Jc4JKTAiZNH48fvfPhNkpcU3lOa5xcZ0Ooip1DnwB4lp7TmWQp1zR8fY4CT5Jn3dwAFyzh9mpwwgLwsKnqa_JiEgHaQwThLXEtmZrlKr2QgHw2G9NrqQaEmtzExN1vsyc290RHeIvkSevSeSKtjiDI4bzxpRjJ168bY-Gg26t7dj2HsnXddSs5ni_QNuTTKeblBGyRaZxSZKBMVhs2mw_Uu-6uTz9LYbiS32Bn0JCZmi-fJk1Z2Hl8czrPk69XlYjpL5zefrqeTeap4XYdUV5nSrJYUdF5IzoumaDjlUuuypZIrwLptlcwkawrGNFcNy6qm0G3ciFaUs7Pkw153MzRr1Cr21MtObHqzlv0onDTi7xtrVmLptqKA-AtQRYHzg0Dvvg3og1gbr7DrpEU3eJFBWdd5BqyI6Ot_0Ds39DaOt6OAMsoq_kAtZYfC2NbFumonKiYFZCUtY-VIvdtTKu7b99geW6Ygdk4RO6eIg1Mi_urPMY_wb2tE4O0eWBmr5Xfzn3IYGWzlA51FuAT2Ez330Rg</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Videla, Luis A.</creator><creator>Corbari, Alicia</creator><creator>Soto-Alarcon, Sandra A.</creator><creator>Ortiz, Macarena</creator><creator>Álvarez, Daniela</creator><creator>Bustamante, Andrés</creator><creator>Valenzuela, R.</creator><creator>Echeverría, Francisca</creator><creator>Muñoz, Patricio</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5055-3795</orcidid><orcidid>https://orcid.org/0000-0002-1788-6667</orcidid></search><sort><creationdate>20180101</creationdate><title>Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT</title><author>Videla, Luis A. ; Corbari, Alicia ; Soto-Alarcon, Sandra A. ; Ortiz, Macarena ; Álvarez, Daniela ; Bustamante, Andrés ; Valenzuela, R. ; Echeverría, Francisca ; Muñoz, Patricio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antioxidants</topic><topic>Cardiovascular disease</topic><topic>Chemistry</topic><topic>Diet</topic><topic>Drug dosages</topic><topic>Endoplasmic reticulum</topic><topic>Fatty acids</topic><topic>Hepatology</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Laboratory animals</topic><topic>Liver diseases</topic><topic>Nutrition research</topic><topic>Omega-3 fatty acids</topic><topic>Oxidative stress</topic><topic>Pharmaceutical industry</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Unsaturated fatty acids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Videla, Luis A.</creatorcontrib><creatorcontrib>Corbari, Alicia</creatorcontrib><creatorcontrib>Soto-Alarcon, Sandra A.</creatorcontrib><creatorcontrib>Ortiz, Macarena</creatorcontrib><creatorcontrib>Álvarez, Daniela</creatorcontrib><creatorcontrib>Bustamante, Andrés</creatorcontrib><creatorcontrib>Valenzuela, R.</creatorcontrib><creatorcontrib>Echeverría, Francisca</creatorcontrib><creatorcontrib>Muñoz, Patricio</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Videla, Luis A.</au><au>Corbari, Alicia</au><au>Soto-Alarcon, Sandra A.</au><au>Ortiz, Macarena</au><au>Álvarez, Daniela</au><au>Bustamante, Andrés</au><au>Valenzuela, R.</au><au>Echeverría, Francisca</au><au>Muñoz, Patricio</au><au>Romero, Francisco J.</au><au>Francisco J Romero</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>13</epage><pages>1-13</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism and hydroxytyrosol (HT; 5 mg/kg/day) exerting antioxidant actions was evaluated on hepatic steatosis and oxidative stress induced by a high-fat diet (HFD; 60% fat, 20% protein, and 20% carbohydrates) compared to a control diet (CD; 10% fat, 20% protein, and 70% carbohydrates) in mice fed for 12 weeks. HFD-induced liver steatosis (i) was reduced by 32% by EPA, without changes in oxidative stress-related parameters and mild recovery of Nrf2 functioning affording antioxidation and (ii) was decreased by 42% by HT, concomitantly with total regain of the glutathione status diminished by HFD, 42% to 59% recovery of lipid peroxidation and protein oxidation enhanced by HFD, and regain of Nrf2 functioning, whereas (iii) combined EPA + HT supplementation elicited 74% reduction in liver steatosis, with total recovery of the antioxidant potential in a similar manner than HT. It is concluded that combined HT + EPA drastically decreases NAFLD development, an effect that shows additivity in HT and EPA effects that mainly relies on HT, strengthening the impact of oxidative stress as a central mechanism underlying liver steatosis in obesity.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>30057681</pmid><doi>10.1155/2018/5109503</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-5055-3795</orcidid><orcidid>https://orcid.org/0000-0002-1788-6667</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1942-0900 |
ispartof | Oxidative medicine and cellular longevity, 2018-01, Vol.2018 (2018), p.1-13 |
issn | 1942-0900 1942-0994 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6051008 |
source | Publicly Available Content Database; Wiley Open Access |
subjects | Antioxidants Cardiovascular disease Chemistry Diet Drug dosages Endoplasmic reticulum Fatty acids Hepatology Inflammation Insulin resistance Laboratory animals Liver diseases Nutrition research Omega-3 fatty acids Oxidative stress Pharmaceutical industry Physiological aspects Proteins Rodents Unsaturated fatty acids |
title | Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attenuation%20of%20High-Fat%20Diet-Induced%20Rat%20Liver%20Oxidative%20Stress%20and%20Steatosis%20by%20Combined%20Hydroxytyrosol-%20(HT-)%20Eicosapentaenoic%20Acid%20Supplementation%20Mainly%20Relies%20on%20HT&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Videla,%20Luis%20A.&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=13&rft.pages=1-13&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2018/5109503&rft_dat=%3Cgale_pubme%3EA602717051%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-d82cd39a10d56a446b6b414add7f1a4c0e9ffca2a3b633d4cb328b6df057dc143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2070131384&rft_id=info:pmid/30057681&rft_galeid=A602717051&rfr_iscdi=true |